Neuroendocrine neoplasia goes molecular — time for a change

Guido Rindi, Bertram Wiedenmann

Risultato della ricerca: Contributo in rivistaArticolo in rivista

7 Citazioni (Scopus)

Abstract

In a cohort of 100 patients with neuroendocrine cancer, the use of NETest enabled earlier prediction of tumour progression and resulted in a reduction in the frequency of follow-up procedures. These outcomes are exciting and promising, but limited in value by the heterogeneity of the study cohort and by suboptimal assay sensitivity and specificity.
Lingua originaleEnglish
pagine (da-a)149-150
Numero di pagine2
RivistaNATURE REVIEWS. CLINICAL ONCOLOGY
Volume16
DOI
Stato di pubblicazionePubblicato - 2019

Keywords

  • NEN

Fingerprint Entra nei temi di ricerca di 'Neuroendocrine neoplasia goes molecular — time for a change'. Insieme formano una fingerprint unica.

Cita questo